Fri 7/21/2017 06:39 ET
DJIA21611.7828.970.13%SOLAR21.450.030.14%GOLD1243.401.370.11%Shanghai3136.7734.501.10%
S&P 5002473.450.490.02%BANKS24.800.010.04%OIL46.730.390.83%Nikkei20100.3744.220.22%
NASDAQ6390.004.970.08%SEMI87.960.190.22%US/EU1.160.011.00%Futures2472.501.250.05%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit (Idera Pharmaceuticals - IDRA)    Stock Due Diligence for All

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add IDRA
  
From: singhtelecom (Rep: 956)Date: 07/16/2017 00:26
Forum: Wall Street Pit - Msg #2682635 - List IDRA msgs Thread #673939125 (Rec: 0)
Interim data from an ongoing phase 2 trial of IMO-2125+ipilumumab in this indication could be announced at the upcoming annual meeting of the European Society for Medical Oncology, ESMO in September. Data on objective response rate from the trial is expected in Q1, 2018. Phase 2 data of another molecule IMO-8400 in dermatomyositis is also expected in the first half of 2018. Median analyst price target is $6 (2.5 times upside potential). Prominent institutions like Baker Brothers and Broadfin hold the stock.

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser singhtelecom: Reward | Watch | IgnoreIDRA: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add IDRA
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.